These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17295165)

  • 1. [Genetic factors in pathogenesis of coronary artery disease in the young].
    Ambroziak M; Budaj A
    Kardiol Pol; 2007 Jan; 65(1):71-8. PubMed ID: 17295165
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism, age and coronary heart disease.
    Kolovou GD; Anagnostopoulou KK
    Ageing Res Rev; 2007 Aug; 6(2):94-108. PubMed ID: 17224309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of adenosine deaminase and early neonatal events: is there an association with susceptibility to coronary artery disease in adult life?
    Bottini E; Gloria-Bottini F
    Cardiology; 2009; 114(2):100-1; author reply 102. PubMed ID: 19420937
    [No Abstract]   [Full Text] [Related]  

  • 5. The connexin 37 gene polymorphism and coronary artery disease in Ireland.
    Horan PG; Allen AR; Patterson CC; Spence MS; McGlinchey PG; McKeown PP
    Heart; 2006 Mar; 92(3):395-6. PubMed ID: 16501201
    [No Abstract]   [Full Text] [Related]  

  • 6. [New biochemical and genetic risk factors for coronary artery diseases].
    Imai Y; Nagai R
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():775-80. PubMed ID: 12735065
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of coronary artery disease with polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene.
    Dalal AB; Tewari D; Tewari S; Sharma MK; Pradhan M; Gupta UR; Sinha N; Agarwal S
    Indian Heart J; 2006; 58(4):330-5. PubMed ID: 19039150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The genetic contribution to coronary disease. The genetic factors related to lipid metabolism].
    da Silva PM
    Rev Port Cardiol; 1999; 18(7-8):735-47. PubMed ID: 10466375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of clotting factors and coronary heart disease.
    Donati MB; Iacoviello L
    Haematologica; 2001 Nov; 86(11 Suppl 2):28-30. PubMed ID: 11926770
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetics in ischaemic heart disease].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2007 Jul; 23(133):5-8. PubMed ID: 18051822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Grammer TB; Renner W; Hoffmann MM; Kleber M; Winkelhofer-Roob BM; Boehm BO; Maerz W
    Free Radic Res; 2009 Jul; 43(7):677-84. PubMed ID: 19526392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.
    Elovainio M; Puttonen S; Pulkki-Råback L; Kivimaki M; Viiri LE; Lehtimaki T; Karhunen P; Viikari J; Raitakari OT; Keltikangas-Jarvinen L
    Neuropsychobiology; 2008; 58(2):91-6. PubMed ID: 18843194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphisms--genetic risk factors for coronary heart disease?].
    Ortlepp JR; Klues HG; Hanrath P
    Dtsch Med Wochenschr; 1999 May; 124(19):600-8. PubMed ID: 10365179
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
    Balcerzyk A; Zak I; Krauze J
    Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives.
    Popov AF; Schulz EG; Hinz J; Schmitto JD; Seipelt R; Koziolek MJ; Rosenberger A; Schoendube FA; Müller GA
    Coron Artery Dis; 2008 Nov; 19(7):429-34. PubMed ID: 18923236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic basis of coronary artery disease: from candidate genes to whole genome analysis.
    Franchini M; Peyvandi F; Mannucci PM
    Trends Cardiovasc Med; 2008 Jul; 18(5):157-62. PubMed ID: 18790385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease.
    Szczeklik W; Sanak M; Rostoff P; Piwowarska W; Jakiela B; Szczeklik A
    Thromb Haemost; 2008 Nov; 100(5):893-8. PubMed ID: 18989535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
    Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
    In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine receptor CX3CR-1 and fractalkine: new factors in the atherosclerosis drama?
    Alexander RW
    Circ Res; 2001 Aug; 89(5):376-7. PubMed ID: 11532896
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically elevated C-reactive protein and vascular disease.
    Morita H; Nagai R
    N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.